drugset / Trial / NCT03217474
Femtosecond Laser-assisted Corneal Debridement for Herpes Simplex Keratitis
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of the study is to learn if adding femtosecond laser-assisted corneal debridement to a standard therapy of oral ganciclovir can help shorten the healing time of herpes simplex epithelial keratitis (HSK).
Timeline
- Start
- 2017-07-20
- Primary completion
- 2018-12-30
- Completion
- 2019-12-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ganciclovir | Small molecule | 200 mg | Oral |